Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2013 Sep;51(9):2950–2958. doi: 10.1128/JCM.01010-13

Identification of Salmonella enterica Serovar Typhi Genotypes by Use of Rapid Multiplex Ligation-Dependent Probe Amplification

Duy Pham Thanh a, Nga Tran Vu Thieu a, Chau Tran Thuy a, Martin Lodén c, Kiki Tuin c, James I Campbell a,e, Nguyen Van Minh Hoang a, Phat Voong Vinh a, Jeremy J Farrar a,e, Kathryn E Holt b, Gordon Dougan d, Stephen Baker a,e,f,
PMCID: PMC3754622  PMID: 23824765

Abstract

Salmonella enterica serovar Typhi, the causative agent of typhoid fever, is highly clonal and genetically conserved, making isolate subtyping difficult. We describe a standardized multiplex ligation-dependent probe amplification (MLPA) genotyping scheme targeting 11 key phylogenetic markers of the S. Typhi genome. The MLPA method demonstrated 90% concordance with single nucleotide polymorphism (SNP) typing, the gold standard for S. Typhi genotyping, and had the ability to identify isolates of the H58 haplotype, which is associated with resistance to multiple antimicrobials. Additionally, the assay permitted the detection of fluoroquinolone resistance-associated mutations in the DNA gyrase-encoding gene gyrA and the topoisomerase gene parC with a sensitivity of 100%. The MLPA methodology is simple and reliable, providing phylogenetically and phenotypically relevant genotyping information. This MLPA scheme offers a more-sensitive and interpretable alternative to the nonphylogenetic subgrouping methodologies that are currently used in reference and research laboratories in areas where typhoid is endemic.

INTRODUCTION

Typhoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), remains a significant cause of mortality and morbidity in many regions of the world (1, 2). S. Typhi is a pathogen that is exclusive to humans, and this exquisite level of host restriction is reflected in the genome and population structure of the organism (3). S. Typhi isolates share an exceptionally high level of genetic conservation, making informative subtyping for local and international epidemiology challenging (3). Many methods involving both phenotypic and genotypic techniques have been developed to differentiate between S. Typhi isolates. Phage typing was long considered the standard method for strain subtyping; however, this technique provides little or no phylogenetic information, is technically intensive, and is only performed in specialized reference laboratories (4, 5). Multilocus sequence typing (MLST) cannot productively be applied to S. Typhi because of its monophyletic nature (6). Other molecular techniques, including random amplified polymorphic DNA PCR (RAPD-PCR), pulsed-field gel electrophoresis (PFGE), and amplified fragment length polymorphisms (AFLP), have some discriminatory power but provide a limited ability to define absolute phylogenetic and epidemiological relationships between isolates (79). More recently, genome sequencing and the identification of single nucleotide polymorphisms (SNPs) have provided the first well-defined phylogenetic framework within which to assign S. Typhi isolates to irrefutable genotypes that can describe the population (1013). These studies revealed that S. Typhi genotypes are globally dispersed but are increasingly dominated by a single genotype (H58), which commonly displays resistance to multiple antimicrobials. H58 isolates frequently harbor multidrug-resistant incompatibility group HI1 (IncHI1) plasmids, as well as mutations in the gyrA gene, which confer reduced susceptibility to fluoroquinolones (7, 13).

While SNP detection and genome sequencing are the gold standards for S. Typhi subtyping (7, 10, 11), these methodologies remain in the domain of research institutions, which have the facilities, expertise, and infrastructure to support these activities. Therefore, there is a translation gap that stands in the way of utilizing genomic information for subtyping S. Typhi in endemic locations. To address this, we have developed a simple transportable method for genotyping S. Typhi that can be performed in a laboratory with only modest molecular biology capabilities.

S. Typhi genomes harbor several genomic insertions and deletions (indels) that we hypothesize to be phylogenetically informative and may be used as markers for inferring genotypes within the S. Typhi population (12). Therefore, we predicted that by assaying for selected indels in the S. Typhi genome, we can infer genotype, rather than having to perform genome-wide SNP analysis or genome sequencing. Multiplex ligation-dependent probe amplification (MLPA) is a PCR method that permits multiple DNA sequence targets to be amplified with a single primer pair (14). The ability of the method to detect DNA signatures, as well as individual SNPs, increases its potential utility and provides a system that can be globally standardized. We have designed, validated, and used an MLPA assay to genotype S. Typhi isolates and investigate the molecular epidemiology of typhoid in Asia. Our data show that S. Typhi MLPA is simple, robust, and comparable to the gold standard of SNP typing, permitting the identification of the major genotypes, as well as mutations that are associated with reduced susceptibility to fluoroquinolones. The method presented here can be applied to other organisms and represents an alternative to MLST, PFGE, genome sequencing, and serotyping when the ability to perform these methods or the methods themselves are limited.

MATERIALS AND METHODS

Bacterial isolates.

A total of 227 Salmonella isolates (217 S. Typhi and 10 S. enterica serovar Paratyphi A) were used in this study (see Table S1 in the supplemental material). All bacterial isolates originated from previous investigations conducted in southern Vietnam between 1993 and 2005 or across seven other Asian countries between 2002 and 2004, as previously described (15). Nineteen S. Typhi isolates that were previously whole-genome sequenced were used as controls for SNP typing and validation of the MLPA method; these isolates were provided by the Wellcome Trust Sanger Institute (United Kingdom) collection and are additionally described in Table S1 in the supplemental material (12). The 10 S. Paratyphi A isolates originated from India and were included as an out-group for SNP genotyping and MLPA analysis.

Microbiological methods.

All bacterial isolates were identified by standard biochemical tests and agglutination with Salmonella-specific antiserum (Murex Diagnostics, Dartford, United Kingdom). Antimicrobial susceptibilities were tested at the time of isolation by the modified Bauer-Kirby disk diffusion method, as recommended by the CLSI guidelines (16). The antimicrobial disks tested were chloramphenicol (CHL) (30 μg), ampicillin (AMP) (10 μg), trimethoprim-sulfamethoxazole (SXT) (1.25/23.75 μg), ofloxacin (OFX) (5 μg), ciprofloxacin (CIP) (5 μg), and nalidixic acid (NAL) (30 μg). MICs were determined by Etest against CIP, NAL, and OFX, according to the manufacturer's recommendations (AB Biodisk, Sweden). Mueller-Hinton agar and antimicrobial disks were purchased from UniPath, Basingstoke, United Kingdom. Escherichia coli strain ATCC 25922 and Staphylococcus aureus strain ATCC 25923 were used as control strains for these assays. The results were interpreted according to current CLSI guidelines (16). An isolate was defined as multidrug resistant (MDR) if it was resistant to chloramphenicol, trimethoprim-sulfamethoxazole, and ampicillin.

PCR amplification and DNA sequencing.

DNA was extracted from all S. Typhi isolates using the Wizard genomic DNA extraction kit (Promega, Fitchburg, WI). Oligonucleotide primers for the amplification of the quinolone resistance-determining regions (QRDRs) in the gyrA and parC genes in S. Typhi were as described in Table 1. PCRs were performed under the following conditions: 92°C for 45 s, 55°C or 62°C (depending on the primer pair) for 45 s, and 74°C for 1 min, for 30 cycles, followed by a final extension step at 74°C for 2 min. DNA sequencing reactions were performed using the CEQ Dye Terminator cycle sequencing (DTCS) quick start kit (Beckman Coulter) and were sequenced using a CEQ 8000 capillary sequencer (Beckman Coulter). All resulting DNA sequences were analyzed using the CEQuence investigator CEQ2000XL (Beckman Coulter) before verification, alignment, and editing in BioEdit software (http://www.mbio.ncsu.edu/BioEdit/bioedit. html). BLASTn at the NCBI was used to compare all resulting gyrA and parC sequences to those of global S. Typhi isolates. PCR amplification was used to confirm the insertion or deletion of the target sequence across all S. Typhi isolates prior to probe design and MLPA analysis; the primers used are shown in Table 1. PCRs were performed using the following conditions: 92°C for 45 s, 55 to 62°C for 45 s, and 74°C for 45 s, for 30 cycles, followed by a final extension step at 74°C for 2 min (Table 1).

Table 1.

Conventional PCR primers targeting S. Typhi indels and SNPs

Primer Primer sequence (5′ to 3′) Targeta Annealing temp (°C) Amplification size (bp)
indelA_F AGCGATGTGATGATCAGGATT Indel A 55 418
indelA_R AATGGCGTGTTCAGTGGATT
indelB_F TCCGTCTCTTTCTCCAGC Indel B 55 368
indelB_R AATTGATGCTGCTGCTGGACG
indelC_F ACGGGTGAAATACTCGAACG Indel C 58 783
indelC_R CACCAAGCAGATTGTTCAGG
indelD_F CGCTATTTTTTCCGCCCATGC Indel D 60 1,451
indelD_R TAATAACATCGGCGTGCCG
indelE_F CCGTCGCCAAAGTGACGC Indel E 55 993
indelE_R CCGTTGAATCGGAAGTAATAATCG
indelF_F AAGCAAATGCTTAGCACCAC Indel F 55 180
indelF_R CAATGCATAAAGTTAATTTAATCAGGA
indelK_F ATGGGTGAGCGCCTCTTTGG Indel K 55 155
indelK_R GACTGGCTGGACATTTTGTG
indelN_F ATGTTTCATGTGTGGGTAGGGTTGCC Indel N 58 720
indelN_R AAGAATGCCCATTGAGCGG
indelQ_F CAACACCCGTGCGGACGAT Indel Q 60 841
indelQ_R AGCTTACTTCCGGCTCCGAC
indelS_F TTGGTGATAAAATTGGCTCGGG Indel S 60 1,116
indelS_R AAAGAATGGAAACCAGAGTTTCC
indelH_F GTGGCAAAACAACGCATCG Indel H 62 6,560
indelH_R CGGTGGAGTTAGTGATGCTGA
GYRA/P1 TGTCCGAGATGGCCTGAAGC gyrA 55 347
GYRA/P2 TACCGTCATAAGTTATCCACG
StmparC1 CTATGCGATGTCAGAGCTGG parC 62 270
StmparC2 TAACAGCAGCTCGGCGTATT
a

Indel sites correspond to those shown in Fig. 1.

MLPA.

All MLPA reagents were manufactured and supplied by MRC-Holland (Amsterdam, The Netherlands). Sixteen S. Typhi-specific MLPA probes were designed according to the manufacturer's recommendations. The probes are described in Table 2 and target 11 S. Typhi indels (B, Q, A, K, E, F, S, C, H, N, and D) (Fig. 1). MLPA was performed according to a standard protocol developed by MRC-Holland, as previously described (14). Briefly, S. Typhi genomic DNA was diluted with Tris-EDTA (TE) buffer to final volume of 5 μl (50 to 200 ng) and heated at 98°C for 10 min in a thermocycler (Bio-Rad). After denaturation, the DNA was hybridized with MLPA reagents at 60°C. After overnight incubation, ligation was performed at 54°C for 15 min, followed by 98°C for 5 min. Ten microliters of the ligation mixture was added to 30 μl of PCR buffer. After equilibration at 60°C, 10 μl of SALSA PCR master mix, containing the labeled forward primer 5′-FAM-GGGTTCCCTAAGGGTTGGA-3′ (FAM, 6-carboxylfluorescein) and the unlabeled reverse primer 5′-GTGCCAGCAAGATCCAATCTAGA-3′, was added. PCR amplification was performed using 35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 45 s, followed by 72°C for 20 min. The resulting MLPA amplicons were examined by agarose gel (3%) electrophoresis and by fragment analysis using an ABI 3130xl capillary electrophoresis system (Applied Biosystems). For fragment analysis, 0.5 μl of PCR amplicon was mixed with 9.25 μl of Hi-Di formamide and 0.25 μl 500 LIZ size standard (GeneScan; Applied Biosystems). The mixture was incubated for 3 min at 95°C, chilled for 10 min, and analyzed. The resulting fragment analysis data were analyzed using GeneMapper v4.0 (Applied Biosystems). Data were analyzed using BioNumerics (Applied Maths, Belgium), and phylogenetic trees were drawn using Dendroscope v2.3.

Table 2.

MLPA probe targets and sequences

MLPA target Fragment/amplicon length (bp) MLPA probe sequencea
parCb 130 TCAATACGACTCTAGATTAGACACCATGGCTTCATAGCAGGCGA
TGTCGCCATGCGGGTGATACTTACCTATTATGCTGAGC
Indel B 139 TTCCGGTCAGACTTGGACGCAAAATACAGGTA
CGAAAGGCCAGCTCGTGAAAATCCATAGAGGGGCT
Indel Q 158 TTATGGACGCTGGTGCAGCAGGAG
CCCTCCCATCCGTTAATTGTTAGTACCACGCTGAACACCG
Indel A 175 TTTTAGTCCATCACGCGCTTCAACATCCGTTC
TATCAGGATGTTGAAAAAGTGGTGCGCATTAATCCACTGAACAC
Indel K 204 TCGACTGGCTGGACATTTTGTGGTTC
TCTGCCGATGCGCTGGAGCAGCTTTGTGATGCGCT
gyrAb,c 238 CCAGCGAGAATGGCTGCGCCATACGAACGA
AATCGCCGTGGGGATGGTATTTACCGATTACGTCACCAACGAC
Indel E 252 GGAACATGGCGATATCAAATCCATCAATG
AAAGCGTCCAGTCCCTGTTTGATGCTCAGTCCCTG
aroC 267 GACAACAACGATAACGGAGCCGTGATGGCA
GGAAACACAATTGGACAACTCTTTCGCGTAACCACTTTCG
Indel S 275 GCTCTCTGGCTTTTTGAACACAGAAATGG
TCGAGTGAAATCAGCTTTGACTTAGCCCTTTTATAAAGCCTTGCGGC
Indel F 308 GCAGTCAGATTTGAACGTCCGGCATAA
AAATAAGTGCTATTAAGCTCTTCAACTGTATCCATACTCTAATTTCCTG
Indel C 362 CTAAAGCGTCGTTGATAATGGTGTAACGGT
GAACTGTCACAGGTCGTGGCGTTATCTTCGATAAACTTCACCT
fliC 374 CTGTTGACCCAGAATAACCTGAACAAATCC
CAGTCCGCACTGGGCACTGCTATCGAGCGTTTGT
Indel H 414 CTTGCTTTACCGAGCAGCATATTCTTTCCGCT
ATGACCGTTCAGTATTTGCAGAAGAAAGGCTTTCAGGTTCAGCC
ssaV 429 CCTGATTCCCTCACCTAACCATGAAC
GCATTGCGACTCCAGAAATTTTATTTGTCGATGATGTAATCGTAACC
Indel N 465 CCAGCACAGGCGTATTATCGCTAACACGCT
CACCAACATAGTCGATTTCATGCCAGTAAACTATTGGTAGCCTGGT
Indel D 494 CCTGGTCAAGCGTTAACTTTATTACTGCCCAT
GACGGCTTCACGCTGAACGATCTGGTGTCTTATAACGA
a

Probes comprise left and right hybridization sequences.

b

Probe contains a nucleotide to detect a specific SNP in the QRDR region (boldface and underlined).

c

gyrA probe requires a spanning oligonucleotide to detect mutations at codons 83 and 87 (TGGTGTCATACACTGCGA).

Fig 1.

Fig 1

Indels in the Salmonella Typhi genome. (a) Phylogenetic tree of S. Typhi derived from SNP data, adapted from Holt et al. (12). The broken line with a black circle designates the ancestral root; all major haplotypes are highlighted (e.g., H58). Capitalized colored letters represent 17 different indels, the position of the indels on the tree indicates the branch with which they are associated, and the asterisks highlight the 11 indels selected for MLPA. (b) Genomic map of S. Typhi strain CT18 from 1 to 4,800,000 bp (coordinates shown). Highlighted are the genomic positions and the strand of the 17 indels and the aroC, ssaV, fliC, gyrA, and parC genes. In the center of the map is a description of the 17 indels (A to S), showing the genomic coordinates (with respect to S. Typhi CT18) and the affected coding sequence(s).

Single nucleotide polymorphism genotyping.

A cross-sectional subset of 73 S. Typhi isolates was arbitrarily selected to encompass a range of locations, antimicrobial resistance patterns, studies in Vietnam, and dates of isolation for gold-standard SNP genotyping using the Illumina GoldenGate platform (see Table S1 in the supplemental material). DNA was extracted from all S. Typhi isolates as described above, and concentrations were assessed using the Quant-iT kit (Invitrogen, Carlsbad, CA) prior to SNP typing. The chromosomal haplotype of S. Typhi isolates was determined based on the SNPs present at 1,485 chromosomal loci identified previously from genome-wide surveys (12, 17). All loci were interrogated using a GoldenGate (Illumina) custom assay according to the manufacturer's standard protocols, as described previously (10, 11, 18, 19). SNP calls were generated from raw fluorescence signal data by clustering with a modified version of Illuminus, as described previously (10, 11, 18, 19). SNP alleles were concatenated to generate a multiple-sequence alignment; maximum likelihood phylogenetic trees were fitted to each alignment using RAxML with a general time reversible plus gamma (GTR+γ) model and 1,000 bootstraps as previously described (11, 20).

RESULTS

Development of MLPA to detect phylogenetically informative indels in the S. Typhi genome.

Data gleaned from genome sequencing predicted that the presence or absence of certain indels within the S. Typhi chromosome might be phylogenetically informative markers for assigning S. Typhi isolates to the genotype groups originally defined by SNP analysis (12). Consequently, conventional PCR assays were designed to independently detect 11 of these previously described indels (12). Each target (A, B, C, D, E, F, H, K, N, Q, and S) was selected to represent one of the main branches of the S. Typhi phylogenetic tree, and where two indels were present on one branch, one was selected to avoid redundancy (Table 1, Fig. 1).

Conventional PCR amplification, detecting indels at the 11 target loci, was performed on DNA extracted from the 19 S. Typhi isolates that had been whole-genome sequenced (12) (Table 3). The PCR amplification results (PCR+/indel+ and PCR/indel) corresponded precisely with the genome sequencing data, confirming the phylogenetic potential of these 11 indel targets in the selected isolates.

Table 3.

Comparison of S. Typhi MLPA indel genotyping and genome sequencing

S. Typhi isolatea Location of isolation Haplotypea Predicted indel pattern as determined by:
Sequencinga MLPA
E98-2068 Bangladesh H42 KB KB
CT18 Vietnam H1 KB KB
J185SM Indonesia H85 KB KB
404ty Indonesia H59 KB KB
E03-4983 Indonesia H59 KBA KBA
AG3 Vietnam H58 KBCE KBCE
8(04)-N Vietnam H58 KBCE KBCE
E02-2759 India H58 KBCE KBCE
E03-9804 India H58 KBCE KBCE
ISP-03-07467 Morocco H58 KBCE KBCE
ISP-04-06979 Central Africa H58 KBCE KBCE
150(98)S Vietnam H63 KBCES KBCES
E98-0664 Kenya H55 K K
M223 Unknown H8 K K
Ty2 Russia H10 KBCS KBCS
E01-6750 Senegal H52 KBCS KBCS
E98-3139 Mexico H50 KF KF
E00-7866 Morocco H46 Q Q
E02-1180 India H45 D D
a

See Holt et al. (12).

An MLPA probe set was designed to detect the same 11 indels, as well as SNPs in the gyrA and parC genes and sequences within the conserved S. Typhi genes aroC, ssaV, and fliC to serve as controls for hybridization, amplification, and detection. The probe sequences and the predicted amplicon length for each target are shown in Table 2. The gyrA and parC probes were designed to detect SNPs associated with reduced susceptibility to fluoroquinolones within the QRDRs. Although several mutations have been identified at gyrA codon 83, the most common mutation associated with fluoroquinolone resistance (TCC to TTC) (15, 21) changes serine to phenylalanine (S83F); thus, the gyrA probe was designed to target this mutation. Additionally, a spanning probe was added to differentiate mutations at codons 83 and 87 within gyrA; it was designed so that a wild-type allele would not yield a detectable DNA fragment and so other (non-S83F) mutations at codons 83 and 87 would generate a product of decreased intensity in comparison to any product yielded from the S83F mutation. The parC probe was designed to detect the most common fluoroquinolone resistance mutation (AGC to ATC), which changes serine to isoleucine at codon 80, and to yield a product only when an S. Typhi isolate contained the S80I mutation (15, 21). The indel type was inferred by the absence of amplification or of peaks following fragment analysis (Fig. 2).

Fig 2.

Fig 2

Salmonella Typhi MLPA indel typing. (a) Fragment analysis generated by MLPA of S. Typhi isolate 113 from Vietnam, demonstrating a KB (H1) indel pattern S. Typhi by MLPA (KB peaks are missing, indicated by broken lines). Each peak corresponds with the fluorescence intensity of amplicons targeting specific loci (labeled at the top of each peak), including a large peak at 238 bp associated with a single gyrA mutation at codon 83. (b) Fragment analysis generated by MLPA of S. Typhi isolate 9019 from Vietnam, demonstrating a KBCE (H58) indel pattern by MLPA (KBCE peaks are missing, indicated by broken lines). This isolate has two gyrA mutations at codons 83 and 87 and a parC mutation, as determined by a diminished peak at 238 bp and large peak at 130 bp, respectively. (c) Representative fragment analysis of S. Typhi MLPA amplicons by agarose gel electrophoresis. Fourteen bands are visible and correspond with the predicted MLPA amplicon lengths shown in Table 2. Lane M, 100-bp marker; lane 1, S. Typhi 113/Vietnam (panel a) KB (gyrA mutation); lane 2, S. Typhi A763/India-KBCEN (gyrA mutation+); lane 3, S. Typhi TY8339/Vietnam-KBC (gyrA mutation); lane 4, S. Typhi DOMIC14/China-ancestral (gyrA mutation); lane 5, S. Typhi DOMIC43/China-ancestral (gyrA mutation); lane 6, S. Typhi TY7045/Vietnam-KBCE (gyrA mutation+); lane 7, S. Typhi J348BM/Indonesia-KBC (gyrA mutation); lane 8, S. Typhi AS3357/Bangladesh-KBC (gyrA mutation); lane 9, S. Typhi DOMI40/China-KS (gyrA mutation); lane 10, DOMI38/China-KS (gyrA mutation).

Validation of MLPA for S. Typhi genotyping and detection of gyrA and parC mutations.

MLPA was performed using DNA prepared from 19 global S. Typhi isolates that were previously whole-genome sequenced (Table 3) (12). Analysis of the DNA fragments generated from these PCR amplifications demonstrated that all probes, including the controls, performed as anticipated, as they produced measurable and reproducible amplicons of the predicted sizes. Representative examples of the resulting DNA fragment analysis and gel electrophoresis are shown in Fig. 2. Notably, the probes targeting the gyrA and parC mutations were able to distinguish between isolates with and without mutations in the QRDR. Figure 2 shows that the parC amplicon was detectable in isolates with a parC mutation, and a diminished gyrA signal was visible in isolates with a mutation at codons 83 and 87. The indel and QRDR patterns of the S. Typhi isolates yielded by MLPA corresponded precisely with the indel patterns and the gyrA and parC mutations anticipated from both the genome sequences and conventional PCR (Table 3).

Next, 73 S. Typhi isolates of undetermined genotype from Bangladesh, China, India, Indonesia, Laos, Pakistan, and Vietnam and 10 S. Paratyphi A isolates from India (as a control) were typed by detecting SNP variations at 1,485 previously identified loci across the S. Typhi genome using a custom GoldenGate assay (see Table S2 in the supplemental material). These data were used to determine a phylogenetic tree, which subdivided the 73 S. Typhi isolates into six main genotype groups, broadly corresponding to those previously defined as H1, H42, H50, H52, H58, and H59 (Fig. 1 and 3) (3, 12). Approximately three-quarters (54/73) of the genotyped S. Typhi isolates belonged to the H58 genotype, including isolates originating from Bangladesh, India, Laos, Pakistan, and Vietnam. As predicted, the 10 S. Paratyphi A isolates fell into the ancestral group of S. Typhi via SNP typing, i.e., were ancestral for all SNPs, as all mutations were S. Typhi specific (data not shown).

Fig 3.

Fig 3

Comparison of MLPA and SNP genotyping for S. Typhi. The phylogenetic tree was determined by detecting SNP variations at 1,485 previously identified loci across the S. Typhi genomes of 73 isolates using a custom GoldenGate assay (see Table S1 in the supplemental material). The resulting tree was used to infer indel patterns (colored capitalized letters) and their associated branches. Examples of S. Typhi strains at pivotal locations throughout the tree are named, and the H58 group (KBCE indel pattern), consisting of 54 strains, is highlighted in blue.

MLPA was then performed on the same 73 S. Typhi isolates (Fig. 3). The H58 complex has a predicted indel pattern of KBCE and all 54 of the H58 (as determined by SNP typing) S. Typhi isolates produced this pattern (Fig. 3). The MLPA indel patterns were also consistent with the SNP genotypes in all of the H1 (KB), H42 (KB), and H59 (KB) isolates (9/9 total). The five isolates belonging to H52 (predicted indel pattern KBCS) produced 3 KBC, 1 KBCS, and 1 KBCD MLPA pattern. The five H50 S. Typhi isolates (with a predicted KF indel pattern) produced four K patterns and one KS pattern. Thus, genotype predictions based on the detection of MLPA indel patterns matched those predicted from SNP-based genotype assignments in 66/73 (90.4%) of the S. Typhi isolates. The 10 S. Paratyphi A isolates produced amplicons for the aroC, fliC, and ssaV genes and produced peaks corresponding with an indel pattern of SF, which does not correlate with any predicted S. Typhi genotype (see Table S1 in the supplemental material).

MLPA of S. Typhi from eight Asian countries.

Subsequently, MLPA typing was performed on an additional 144 S. Typhi isolates of undetermined genotype from Vietnam (88 isolates) and seven other Asian countries. The MLPA results were combined with data from the 73 S. Typhi isolates typed during validation (see Tables S1 and S2 in the supplemental material). According to antimicrobial susceptibility testing, 119/217 (54.8%) isolates were nalidixic acid resistant (NALR) and 82/217 (37.8%) isolates were MDR (Table 4), and 71 isolates (32.7%) were both NALR and MDR (Fig. 4). We also used the gyrA and parC MLPA amplicons to detect the presence of NALR-conferring mutations and compared these data to the antimicrobial susceptibility results (Table 4, Fig. 4).

Table 4.

MLPA indel genotyping of 217 Asian S. Typhi isolates

MLPA indel patterna No. of isolates Country of isolation (no.) No. with gyrA mutation detected by MLPA No. with resistance type
Nalidixic acid Multidrug
KBCE 118 Vietnam (79), Bangladesh (9), India (18), Pakistan (5), Laos (6), Nepal (1) 93 99 73
KBCEN 10 India (5), Nepal (3), Pakistan (2) 7 10 2
KBCES 4 Vietnam (4) 2 2 3
KB 41 Vietnam (4), Bangladesh (5), India (3), Pakistan (5), Laos (8), Nepal (8), China (1), Indonesia (7) 3 5 4
KBC 12 Vietnam (1), Bangladesh (1) China (9), Indonesia (1) 0 0 0
KBCS 2 Laos (2) 0 0 0
KBCD 1 Laos (1) 0 0 0
K 22 Bangladesh (1), India (2), Pakistan (6), Nepal (2), China (1), Indonesia (6), Laos (4) 1 2 0
KS 3 China (3) 0 0 0
KE 2 India (1), Bangladesh (1) 0 1 0
No deletions (ancestral) 2 China (2) 0 0 0
Total isolates 217 106 119 82
a

Five S. Paratyphi controls gave an indel pattern of SF and were not included in this table (see Table S1 in the supplemental material).

Fig 4.

Fig 4

MLPA indel typing of 217 Asian S. Typhi isolates. The phylogenetic tree was determined by detecting SNP variations at 1,485 previously identified loci across the S. Typhi genomes of 73 isolates using a custom GoldenGate assay inferring the genotype of 217 Asian S. Typhi isolates by MLPA. The color coding and labeling is as shown in Fig. 3. The numbers of isolates with a specific indel type are shown, color coded, and associated with a heat map showing the presence (red) or absence (blue) of a NALR phenotype, a mutation in the QRDR of the gyrA gene by MLPA, a mutation in the QRDR of the parC gene by MLPA, and an MDR phenotype.

We detected 10 different indel patterns in the 217 S. Typhi isolates (Fig. 4, Table 4). Fifty-nine percent of the isolates (128/217) produced a KBCE or KBCEN MLPA pattern, corresponding to the H58 genotype (Table 4, Fig. 4). This H58 group included 90% of isolates from Vietnam (79/88), 79% of isolates from India (23/29), 53% of isolates from Bangladesh (9/17), 39% of isolates from Pakistan (7/18), 31% of isolates from Laos (6/21), and 29% of isolates from Nepal (4/14). We additionally identified 4 isolates with a KBCES indel pattern, and 41 isolates (18%) with a KB indel pattern (H42 haplotype) were identified and spanned all eight Asian countries. Twelve isolates (6%) produced a KBC (H52) indel pattern, and 22/217 (10%) isolates produced a K indel pattern. An additional three indel patterns (KE, KS, and KBCS) were identified across seven isolates, and two Chinese isolates produced amplicons for all loci and were deemed to be ancestral.

MLPA detected 106 isolates with an amplicon consistent with a mutation in gyrA and two isolates with a mutation in parC and a double mutation in gyrA; all were confirmed by sequencing (Fig. 4, Table 4). Of the 119 isolates with phenotypic NALR, 106 (90%) tested positive for a gyrA mutation by MLPA (Table 4). The MLPA analysis revealed that the H58 indel patterns KBCE and KBCEN had an increased proportion of NALR isolates compared to other indel patterns (H58 NALR, non-H58 NALR) (P < 0.0001, Fisher's exact test; see Table 4). Furthermore, the same H58 indel group had an increased proportion of MDR strains compared to other indel patterns (H58 MDR versus non-H58 MDR) (P < 0.0001, Fisher's exact test).

DISCUSSION

Phylogenetically informative subgrouping is vital for understanding the local and regional strain circulations of bacterial pathogens. Diagnostic, research, and reference laboratories use a range of typing methods for recording and reporting bacterial diversity with a variety of pathogens (22, 23). However, these methods often lack reproducibility, sensitivity, and phylogenetic relevance (24). The consequence of these limitations is an inability to perform robust epidemiological investigations of circulating bacterial pathogens. Genomics offers a solution to these limitations, and DNA sequence-based methodologies can be used to improve bacterial subtyping (10, 25, 26). However, whole-genome sequencing is currently too specialized and expensive to be employed in areas where typhoid is endemic. We aimed to address this and developed a simple and reproducible S. Typhi subtyping method that can be performed in locations with limited molecular biology equipment. The MLPA method utilizes a limited number of steps and can be conducted with a standardized set of reagents and protocols. The method we developed performs well and can be made commercially available, depending on the demand within the enteric fever research community. It is difficult to perform a direct cost comparison of MLPA and sequencing, as demand impacts the cost of the MLPA kit; however, we estimate a cost in the realm of $10 to $20 per isolate for MLPA compared to the current cost of $500 to $1,000 per isolate for next-generation sequencing (price estimated on 5× to 15× coverage of a whole S. Typhi genome, using a 454 Junior next-generation sequencer with current costs in Vietnam; this could be reduced by using commercial sequencing facilities).

The MLPA method successfully detected all 11 phylogenetically informative indels, permitting us to infer a genotype for each. In our test set of 73 S. Typhi isolates, MLPA indel patterns accurately predicted SNP-based genotype assignments in 90% of the strains. For the remaining isolates, the MLPA profiles were a combination of indels that were similar, but not identical, to those we anticipated from SNP genotypes. Our method also permitted the incorporation of probes targeting the QRDR regions of gyrA and parC. The ability to detect mutations in gyrA and parC is highly relevant for epidemiological studies of S. Typhi, as NALR S. Typhi has been reported in the majority of countries where typhoid is endemic (15, 19, 21, 27). NALR is a reliable marker of isolates with a reduced susceptibility to fluoroquinolones, the most common group of antimicrobials used to treat typhoid. When treated with fluoroquinolones, NALR S. Typhi is associated with an extended fever clearance time, prolonged antimicrobial therapy, and an increased risk of treatment failure (28). Therefore, knowing the prevalence of gyrA mutations in endemic locations is important for treatment and is of value to epidemiologists, clinicians, and those making guidelines for clinical care.

Among the 106 isolates in which NALR mutations were detected by MLPA, all gyrA and parC mutations were confirmed by direct PCR amplicon sequencing, indicating 100% specificity for the detection of mutations in these genes using MLPA. Notably, we detected only two strains containing the parC mutation; these strains were from India, confirming our previous observation that this mutation is rare and has only been identified in strains circulating in India (15). There were 13 NALR isolates that tested negative for gyrA and parC mutations using MLPA; direct sequencing of the amplicons confirmed the MLPA data. We suggest that this 10% discrepancy between MLPA and NALR phenotypic data was caused by either fluctuation in zone size readings during antimicrobial susceptibility testing by disk diffusion or by novel mutations in the QRDR that were not represented in this assay (15). The successful use of MLPA to identify point mutations is encouraging and suggests that this method can be adapted to establish a simple and robust alternative to SNP typing for S. Typhi and other monomorphic pathogens, which may be more phylogenetically informative than the use of genomic indels.

The potential limitations of our work include the lack of an incHI1 plasmid probe, a bias toward isolates from Vietnam, and the fact that some indel profiles are shared by several genetically diverse S. Typhi genotypes, while other indel profiles define much more homogeneous groups. Hence, the resolution offered by indel typing is somewhat varied. We suggest that the discrepancies between SNP and MLPA typing are induced by the stability of some indels in different lineages, predicting that some indel loci may not be as phylogenetically informative as others. However, notwithstanding these limitations, our comparison of genome-wide SNP with MLPA typing showed that MLPA was able to distinguish between five common S. Typhi isolates and, most significantly, was able to correctly identify H58 strains from Vietnam and across Asia. Principally, we were able to distinguish H58 strains with and without gyrA mutations with 100% accuracy. It has been shown that H58 strains currently predominate in the majority of endemic locations, and there is an association between H58 strains and S83F gyrA mutations and an MDR phenotype (3, 13). The MLPA data confirmed that H58 S. Typhi is dominant in Vietnam and is widely dispersed across Asia, and it is associated with both NALR and MDR in these regions. As the use of high-resolution SNP typing and genome sequencing have previously reported similar associations, the ability of MLPA to reproduce this result confirms its reliability and potential utility for epidemiological investigations. We advocate a new system for the subtyping of S. Typhi and propose that indel detection, either by MLPA or conventional PCR, be adopted until SNP typing becomes more routine. We aim to develop a global Web-based S. Typhi, S. Paratyphi A, invasive nontyphoidal Salmonella reference network whereby serotyping is combined with simple genotyping information, antimicrobial resistance profiling, and the time and date of isolation. The use of a standardized kit-based assay, such as the one presented here, that can be adapted through targeted genome sequencing would allow for routine data sharing and a global resource for assessing international epidemiology and defining appropriate measures for therapy and vaccination.

In conclusion, we have developed a simple, reliable, and epidemiologically relevant method that can be used in laboratories with modest molecular biology equipment to subgroup S. Typhi and identify common NALR-associated mutations. This MLPA method can distinguish between strains that currently dominate the global population structure of S. Typhi, offering a more sensitive and simple alternative to other subgrouping methodologies that are currently being used in low- and middle-income countries.

Supplementary Material

Supplemental material

ACKNOWLEDGMENTS

This work was supported by the Wellcome Trust and fellowship schemes from the NHMRC of Australia (no. 628930, to K.E.H.) and the OAK foundation of the United States. S.B. is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant no. 100087/Z/12/Z). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.

Footnotes

Published ahead of print 3 July 2013

Supplemental material for this article may be found at http://dx.doi.org/10.1128/JCM.01010-13.

REFERENCES

  • 1.Crump JA, Luby SP, Mintz ED. 2004. The global burden of typhoid fever. Bull. World Health Organ. 82:346–353 [PMC free article] [PubMed] [Google Scholar]
  • 2.Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. 2002. Typhoid fever. N. Engl. J. Med. 347:1770–1782 [DOI] [PubMed] [Google Scholar]
  • 3.Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, Chinh NT, Le TAH, Acosta CJ, Farrar J, Dougan G, Achtman M. 2006. Evolutionary history of Salmonella Typhi. Science 314:1301–1304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kim S, Kim SH, Park JH, Lee KS, Park MS, Lee BK. 2009. Clustering analysis of Salmonella enterica serovar Typhi isolates in Korea by PFGE, ribotying, and phage typing. Foodborne Pathog. Dis. 6:733–738 [DOI] [PubMed] [Google Scholar]
  • 5.Sen B, Dutta S, Sur D, Manna B, Deb AK, Bhattacharya SK, Niyogi SK. 2007. Phage typing, biotyping & antimicrobial resistance profile of Salmonella enterica serotype Typhi from Kolkata. Indian J. Med. Res. 125:685–688 [PubMed] [Google Scholar]
  • 6.Kidgell C, Reichard U, Wain J, Linz B, Torpdahl M, Dougan G, Achtman M. 2002. Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old. Infect. Genet. Evol. 2:39–45 [DOI] [PubMed] [Google Scholar]
  • 7.Kariuki S, Gilks C, Revathi G, Hart CA. 2000. Genotypic analysis of multidrug-resistant Salmonella enterica serovar Typhi, Kenya. Emerg. Infect. Dis. 6:649–651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nair S, Schreiber E, Thong KL, Pang T, Altwegg M. 2000. Genotypic characterization of Salmonella Typhi by amplified fragment length polymorphism fingerprinting provides increased discrimination as compared to pulsed-field gel electrophoresis and ribotyping. J. Microbiol. Methods 41:35–43 [DOI] [PubMed] [Google Scholar]
  • 9.Thong KL, Cheong YM, Puthucheary S, Koh CL, Pang T. 1994. Epidemiologic analysis of sporadic Salmonella Typhi isolates and those from outbreaks by pulsed-field gel electrophoresis. J. Clin. Microbiol. 32:1135–1141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Baker S, Holt KE, Clements ACA, Karkey A, Arjyal A, Boni MF, Dongol S, Hammond N, Koirala S, Duy PT, Nga TV, Campbell JI, Dolecek C, Basnyat B, Dougan G, Farrar JJ. 2011. Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission. Open Biol. 1:110008. 10.1098/rsob.110008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Holt KE, Dolecek C, Chau TT, Duy PT, La TT, Hoang NV, Nga TV, Campbell JI, Manh BH, Vinh Chau NV, Hien TT, Farrar J, Dougan G, Baker S. 2011. Temporal fluctuation of multidrug resistant Salmonella Typhi haplotypes in the Mekong river delta region of Vietnam. PLoS Negl. Trop. Dis. 5:e929. 10.1371/journal.pntd.0000929 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, Goodhead I, Rance R, Baker S, Maskell DJ, Wain J, Dolecek C, Achtman M, Dougan G. 2008. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat. Genet. 40:987–993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Holt KE, Phan MD, Baker S, Duy PT, Nga TVT, Nair S, Turner AK, Walsh C, Fanning S, Farrell-Ward S, Dutta S, Kariuki S, Weill FX, Parkhill J, Dougan G, Wain J. 2011. Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl. Trop. Dis. 5:e1245. 10.1371/journal.pntd.0001245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. 2002. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30:e57. 10.1093/nar/gnf056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Parry CM, Thuy CT, Dongol S, Karkey A, Vinh H, Chinh NT, Duy PT, Thieu Nga TV, Campbell JI, Van Minh Hoang N, Arjyal A, Bhutta ZA, Bhattacharya SK, Agtini MD, Dong B, Canh do G, Naheed A, Wain J, Tinh Hien T, Basnyat B, Ochiai L, Clemens J, Farrar JJ, Dolecek C, Baker S. 2010. Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones. Antimicrob. Agents Chemother. 54:5201–5208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Clinical and Laboratory Standards Institute 2012. Performance standards for antimicrobial disk susceptibility tests; approved standard—eleventh edition. CLSI document M02-A11 Clinical and Laboratory Standards Institute, Wayne, PA [Google Scholar]
  • 17.Phan MD, Kidgell C, Nair S, Holt KE, Turner AK, Hinds J, Butcher P, Cooke FJ, Thomson NR, Titball R, Bhutta ZA, Hasan R, Dougan G, Wain J. 2009. Variation in Salmonella enterica serovar Typhi IncHI1 plasmids during the global spread of resistant typhoid fever. Antimicrob. Agents Chemother. 53:716–727 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Holt KE, Baker S, Dongol S, Basnyat B, Adhikari N, Thorson S, Pulickal AS, Song Y, Parkhill J, Farrar JJ, Murdoch DR, Kelly DF, Pollard AJ, Dougan G. 2010. High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children. BMC Infect. Dis. 10:144. 10.1186/1471-2334-10-144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kariuki S, Revathi G, Kiiru J, Mengo DM, Mwituria J, Muyodi J, Munyalo A, Teo YY, Holt KE, Kingsley RA, Dougan G. 2010. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J. Clin. Microbiol. 48:2171–2176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Stamatakis A. 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22:2688–2690 [DOI] [PubMed] [Google Scholar]
  • 21.Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, Nga TT, Van Vinh Chau N, Tuan PQ, Page AL, Ochiai RL, Schultsz C, Wain J, Bhutta ZA, Parry CM, Bhattacharya SK, Dutta S, Agtini M, Dong B, Honghui Y, Anh DD, Canh do G, Naheed A, Albert MJ, Phetsouvanh R, Newton PN, Basnyat B, Arjyal A, La TT, Rang NN, Phuong le T, Van Be Bay P, von Seidlein L, Dougan G, Clemens JD, Vinh H, Hien TT, Chinh NT, Acosta CJ, Farrar J, Dolecek C. 2007. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob. Agents Chemother. 51:4315–4323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Boxrud D, Monson T, Stiles T, Besser J. 2010. The role, challenges, and support of PulseNet laboratories in detecting foodborne disease outbreaks. Public Health Rep. 125(Suppl 2):57–62 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gerner-Smidt P, Scheutz F. 2006. Standardized pulsed-field gel electrophoresis of Shiga toxin-producing Escherichia coli: the PulseNet Europe Feasibility study. Foodborne Pathog. Dis. 3:74–80 [DOI] [PubMed] [Google Scholar]
  • 24.Baker S, Hanage WP, Holt KE. 2010. Navigating the future of bacterial molecular epidemiology. Curr. Opin. Microbiol. 13:640–645 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, McGee L, von Gottberg A, Song JH, Ko KS, Pichon B, Baker S, Parry CM, Lambertsen LM, Shahinas D, Pillai DR, Mitchell TJ, Dougan G, Tomasz A, Klugman KP, Parkhill J, Hanage WP, Bentley SD. 2011. Rapid pneumococcal evolution in response to clinical interventions. Science 331:430–434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Harris SR, Feil EJ, Holden MTG, Quail MA, Nickerson EK, Chantratita N, Gardete S, Tavares A, Day N, Lindsay JA, Edgeworth JD, de Lencastre H, Parkhill J, Peacock SJ, Bentley SD. 2010. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327:469–474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kumar Y, Sharma A, Mani KR. 2009. High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in central India. J. Infect. Dev. Ctries. 3:467–469 [DOI] [PubMed] [Google Scholar]
  • 28.Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, Hien TT, Farrar JJ, Baker S. 2011. The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl. Trop. Dis. 5:e1163. 10.1371/journal.pntd.0001163 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental material

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES